Open to Global and Asian pharmaceutical and biotech companies only, the Best Therapeutic Vaccine Award recognised the company that had set the best strategy of developing specific vaccines to address the unmet medical needs in Asia.
The nominees were judged on the following criteria:
- Candidates addressing current unmet medical needs
- Significant potential for vast geographical and market reach
- Possession of a novel mode of action or technology
- Progress through clinical trials and achieved milestones
- Strong safety and risk management data
The World Vaccine Congress Asia Team congratulations MSD on its win! To find out more about the awards, visit: http://www.terrapinn.com/vaccineasia